Pneumonia News and Research

Latest Pneumonia News and Research

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.

19 Dec 2011

Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease

Pfizer Inc. today announced it has entered into a second supply agreement which will broaden and extend the duration of the Company's commitment to help protect millions of infants and young children in the developing world from pneumococcal disease - the leading cause of vaccine-preventable death in young children.

17 Dec 2011

Research roundup: Insurance coverage in the Great Recession; PCIP vs. CHIP

The researchers how physicians examined claims of lower back back pain and note that part of the "rising economic cost of this epidemic is the burgeoning use of indiscriminate imaging," specifically MRIs. Researchers divided patients into two groups and "the treating physician in group 1 patients was blinded to the MRI results, while the physician for group 2 patients decided on treatment after reviewing the MRI findings."

17 Dec 2011

3-year study identifies key interventions to reduce maternal, newborn, child deaths

A three-year study conducted by the WHO, Aga Khan University, and the Partnership for Maternal, Newborn & Child Health (PMNCH) "has identified key interventions to reduce maternal, newborn and child deaths," PANA/Afrique en Ligne reports.

17 Dec 2011

Study aims to reduce mortality disparities by education

A study in the December issue of the American Sociological Review has brought new understanding as to why death rates for less educated middle aged adults are much higher than for their more educated peers despite increased awareness and treatments aimed at reducing health disparities.

16 Dec 2011

Evidence-based interventions to reduce newborn and maternal mortality

Some 56 evidence-based interventions will sharply reduce the 358,000 women who still die each year during pregnancy and childbirth and the 7.6 million children who die before the age of 5, according to a massive three-year global study.

16 Dec 2011

Statins linked with reduced risk of death among hospitalized flu patients

The two main ways to prevent and control influenza today are annual immunization and antiviral drugs. A team of investigators has found that statins, cholesterol-lowering drugs, may offer an additional treatment to complement these approaches and reduce mortality among patients hospitalized with influenza.

14 Dec 2011

Celgene announces results from azacitidine Phase 1 study on AML

Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.

12 Dec 2011

Prevention practices for catheter-associated urinary tract infections lacking in most hospitals

Hospitals are working harder than ever to prevent hospital-acquired infections, but a nationwide survey shows few are aggressively combating the most common one - catheter-associated urinary tract infections.

9 Dec 2011

Experimental sublingual vaccine shows promise against influenza infection

Scientists from the International Vaccine Institute (IVI) have discovered that an antigen common to most influenza viruses, and commonly referred to as matrix protein 2 (M2), when administered under the tongue could protect mice against experimental infection caused by various influenza viruses, including the highly pathogenic avian H5 virus and the pandemic H1 ("swine flu") virus.

9 Dec 2011

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Updated results of a Phase III study of Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, show everolimus provided additional time women with advanced breast cancer lived without their disease progressing.

8 Dec 2011

UH Case Medical Center designated as 'Top Hospital' and leader in quality patient care

University Hospitals Case Medical Center in Cleveland, Ohio is among 65 hospitals nationwide to be designated as a "Top Hospital" and leader in quality patient care by The Leapfrog Group.

7 Dec 2011

Plasma can inactivate and prevent replication of adenoviruses

Life-threatening viruses such as HIV, SARS, hepatitis and influenza, could soon be combatted in an unusual manner as researchers have demonstrated the effectiveness of plasma for inactivating and preventing the replication of adenoviruses.

5 Dec 2011

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis Pharmaceuticals Corporation will showcase more than one hundred and sixty presentations on data from its robust oncology portfolio at two key medical congresses this month, demonstrating significant advances for patients with cancers and hematological diseases.

3 Dec 2011

Study examines alternative immunization schedule occurrence rates in Washington State

Seventy-seven percent of Washington state pediatricians report that they are sometimes or frequently asked to provide alternative childhood vaccine schedules for their patients, according to a new study from Seattle Children's Research Institute. Researchers also found that 61 percent of Washington state pediatricians are comfortable using an alternative schedule when asked by a parent.

30 Nov 2011

Enrollment complete in Alnylam's ALN-RSV01 Phase IIb study for RSV infection

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has completed patient enrollment in its Phase IIb study with ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection.

29 Nov 2011

New glycoconjugate vaccine prototype more effective than traditional vaccines

Brigham and Women's Hospital (BWH) researchers have created a vaccine that is more potent than traditional vaccines available today. The glycoconjugate vaccine prototype is 100 times more effective than traditional glycoconjugate vaccines. Their work is published in the December 2011 issue of Nature Medicine.

29 Nov 2011

Pediatricians frequently asked to provide alternative childhood vaccine schedules

29 Nov 2011

Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC

Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that based on the recommendation from the Data Monitoring Committee (DMC) it will discontinue its pivotal double-blinded Phase III MAINSAIL trial that was designed to evaluate the efficacy and safety of docetaxel and prednisone with or without lenalidomide in patients with castrate-resistant prostate cancer.

23 Nov 2011

Despite market constraints, the drug market for key hospital-treated infections will increase: Report

Decision Resources finds that the drug market for key hospital-treated infections that are of high interest to drug developers—most notably nosocomial pneumonia, bloodstream infections, skin and skin structure/surgical site infections and urinary tract infections—will increase from $3.3 billion in 2010 to just over $4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

21 Nov 2011

Pneumonia News and Research

Latest Pneumonia News and Research

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease

Research roundup: Insurance coverage in the Great Recession; PCIP vs. CHIP

3-year study identifies key interventions to reduce maternal, newborn, child deaths

Study aims to reduce mortality disparities by education

Evidence-based interventions to reduce newborn and maternal mortality

Statins linked with reduced risk of death among hospitalized flu patients

Celgene announces results from azacitidine Phase 1 study on AML

Prevention practices for catheter-associated urinary tract infections lacking in most hospitals

Experimental sublingual vaccine shows promise against influenza infection

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

UH Case Medical Center designated as 'Top Hospital' and leader in quality patient care

Plasma can inactivate and prevent replication of adenoviruses

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Study examines alternative immunization schedule occurrence rates in Washington State

Enrollment complete in Alnylam's ALN-RSV01 Phase IIb study for RSV infection

New glycoconjugate vaccine prototype more effective than traditional vaccines

Pediatricians frequently asked to provide alternative childhood vaccine schedules

Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC

Despite market constraints, the drug market for key hospital-treated infections will increase: Report

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Pneumonia News and Research

Latest Pneumonia News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in